Posts in category

In Depth


Debbie Rigby rounds up the latest in research news Balancing the Risks and Benefits of Benzodiazepines This article is a viewpoint on the risks and benefits of benzodiazepines, showing risk …

The pharmacy real estate market is staying strong, but has divided into two tiers during COVID, says Natalie Sirianni As a pharmacy business broker, and someone who spends a lot …

Pharmacists have a crucial role to play in identifying fungal infections and educating patients on the best course of treatment It’s commonplace for people to visit their local pharmacy seeking …

Why does this keep happening? asks Michael Toole, Burnet Institute Here’s a newspaper headline from May 27, 2020: “Worker at Melbourne quarantine hotel tests positive for COVID-19”. And here’s one …

Keep an eye out for patients coming in to buy anti-diarrhoeals and pain medicines, write Esther Lau and Lisa Nissen Everyone can relate to symptoms like abdominal pain, bloating, constipation, …

‘Pushing the boundaries of traditional pharmacist practice’: AJP chats with a Brisbane fertility pharmacist about her innovative role and what it involves What is a fertility pharmacist, you ask? Well, …

Angelo Pricolo reflects on noisier and more frustrating times in community pharmacy… and a new, intrusive menace The pharmacy has become a quieter place as technology has improved conditions. The …

Debbie Rigby rounds up the latest in research news Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes A large systematic review and network …

The decision to make nicotine-containing e-cigarettes Prescription-Only from October places pharmacists at the frontline of counselling on a highly controversial product In late December, the TGA confirmed its decision on …

Louis Roller takes a look at psoriasis, its treatments and comorbidities Psoriasis is a chronic inflammatory skin and joint disorder characterised by erythema and scale. Men and women are equally …

Here’s why it’s still too soon, write Stephen Bright, from Edith Cowan University and Martin Williams, from Monash University While the public focus remains on COVID vaccines, the Therapeutic Goods …

Debbie Rigby rounds up the latest in research news Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease Long‐term use of proton pump inhibitors (PPIs) has been …